Ada D’Addosio

Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

Maria Teresa Voso, Susanna Fenu, Roberto Latagliata et al. · Journal of Clinical Oncology · 2013 · 137 citations · Full text

Medicine, Hematology, Internal Medicine +17

Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Study

Roberto Latagliata, Dario Ferrero, Alessandra Iurlo et al. · Drugs & Aging · 2013 · 43 citations

Medicine, Hematology, Oncology +8

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival

Massimo Breccia, Luigiana Luciano, Roberto Latagliata et al. · Leukemia Research · 2014 · 35 citations

Medicine, Geriatric Medicine, Oncology +12

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome

Alessandra Iurlo, Alessandro Nobili, Roberto Latagliata et al. · Oncotarget · 2016 · 35 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Deferasirox chelation therapy in patients with transfusion‐dependent <scp>MDS</scp>: a ‘real‐world’ report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata

Luca Maurillo, Massimo Breccia, Francesco Buccisano et al. · European Journal Of Haematology · 2015 · 25 citations

Medicine, Hematology, Pharmacotherapy +17